Bristol-Myers’ R&D revamp mirrors upheaval in Opdivo’s lung cancer fortunes esagonowsky Thu, 03/09/2017 – 10:51 More: Bristol-Myers' R&D revamp mirrors upheaval in Opdivo's lung cancer fortunes Source: fierce
read moreAs U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters esagonowsky Thu, 03/09/2017 – 10:37 More: As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters Source: fierce
read moreAbbVie chief’s $20M-plus pay—and company jet-setting—headed skyward in 2016 chelfand Thu, 03/09/2017 – 10:23 More: AbbVie chief's M-plus pay—and company jet-setting—headed skyward in 2016 Source: fierce
read moreChina pledges to speed up approvals of foreign drugs aliu Thu, 03/09/2017 – 10:15 More: China pledges to speed up approvals of foreign drugs Source: fierce
read moreMerck KGaA in advanced talks to sell off biosims unit—and others could follow chelfand Thu, 03/09/2017 – 09:03 More: Merck KGaA in advanced talks to sell off biosims unit—and others could follow Source: fierce
read moreCancer experts are calling for a reform of outdated European regulations which they are argue are preventing cancer treatments from being trialled in children. More: Cancer experts urge reform of paediatric cancer trial rules Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals